# ERIBULIN MESYLATE

NDC: 39822-2080
Generic name: eribulin mesylate
Labeler / Manufacturer: XGen Pharmaceuticals DJB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260407

FDA application: ANDA219054

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"39822-2080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=39822-2080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d3a9ac3-10e9-cad5-e063-6394a90a461f